SYNTHETIC

SYN AMEX
0.5199
+0.0090
+1.76%
Opening 11:31 07/23 EDT
Open
0.5355
Prev Close
0.5109
High
0.5355
Low
0.5135
Volume
18.18K
Avg Vol (3M)
102.06K
52 Week High
8.00
52 Week Low
0.4850
% Turnover
0.11%
Market Cap
8.74M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers SYNTHETIC SYN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Synthetic Biologics, Inc. is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Company's lead product candidates in Phase II development are SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Its other product candidates include SYN-007, SYN-006, SYN-005, SYN-200 and SYN-020. The Company is also developing preclinical-stage monoclonal antibody therapies for the prevention and treatment of pertussis, and discovery-stage biotherapeutics for the treatment of phenylketonuria (PKU).
MORE >

Recently

Name
Price
%Change